Real-world outcomes of venetoclax refractory multiple myeloma patients.

Kathryn T. Maples,Jonathan L. Kaufman,Vikas A. Gupta,Nisha Joseph,Leonard T. Heffner,Craig C. Hofmeister,Madhav V. Dhodapkar,Shannon M. Matulis,Lawrence H. Boise,Sagar Lonial,Ajay K. Nooka

Real-world outcomes of venetoclax refractory multiple myeloma patients.

2020

Kathryn T. Maples
Jonathan L. Kaufman
Vikas A. Gupta
Nisha Joseph
Leonard T. Heffner
Craig C. Hofmeister
Madhav V. Dhodapkar
Shannon M. Matulis
Lawrence H. Boise
Sagar Lonial
Ajay K. Nooka

e20524Background: The BELLINI trial investigated the efficacy and safety of venetoclax (ven)/bortezomib (bort)/dexamethasone (dex) vs placebo/bort/dex in patients with bort-sensitive, early relapse...

Keywords:

Venetoclax
Oncology
real world outcomes
Internal medicine
Physical therapy
Medicine
Refractory Multiple Myeloma

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations